Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis

Tildrakizumab, an IL-23 inhibitor, is effective and safe for the improvement of moderate-to-severe chronic plaque psoriasis. However, little evidence is available on the use of this biologic in psoriasis in difficult-to-treat locations. In this retrospective analysis, we treated patients with 100 mg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Marco Galluzzo, Marina Talamonti, Arnaldo Cioni, Virginia Maffei, Ruslana Gaeta Shumak, Lorenzo Tofani, Luca Bianchi, Elena Campione
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2022-05-01
Colecção:Journal of Clinical Medicine
Assuntos:
psoriasis
tildrakizumab
PASI
NAPSI
PSSI
sPGA-G
Acesso em linha:https://www.mdpi.com/2077-0383/11/9/2631
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados